STOCK MARKET BSE NSE

Record-breaking COVID vaccines: Can they keep us safe from mutant variants?

The COVID-19 virus is changing and shape-shifting—a process called mutation—into newer and faster-spreading variants.

Published: 17th January 2021 12:46 PM  |   Last Updated: 17th January 2021 02:20 PM   |  A+A-

Covaxin

A health official shows a Covaxin vaccine dose after a consignment of the vaccine arrived at Kalawati Saran hospital in New Delhi. (Photo | Shekhar Yadav, EPS)

By Express News Service

The Covid-19 virus is changing and shape-shifting—a process called mutation—into newer and faster-spreading variants. The world is sitting up and asking: what’s going on? Should we be worried? What exactly does it mean for us? A look at the vaccines we have at our disposal and if their ability to quell the new variants:

VACCINE: Comirnaty (BNT162b2)

By: Pfizer and BioNTech 

Type: mRNA-based vaccine started January 2020 

Dosage: Two doses, 28 days apart

For: US, Canada, EU, UK, Switzerland, Israel

Efficacy: 95%

Effect on mutant variants? New research suggests their vaccine can protect against mutation found in the two variants that have erupted in Britain and South Africa.

VACCINE: mRNA-1273

By: Moderna, US biotech firm

Type: mRNA-based vaccine

Dosage: Two doses, 28 days apart

For: US, Canada, EU, UK, Switzerland, Israel

Efficacy: 94.1%

Effect on mutant variants? Moderna expects that the immunity induced by its Covid-19 vaccine would be protective against coronavirus variants. “We plan to run tests to confirm the activity of the vaccine against any strain,” said its statement.

VACCINE: Covid-19 Vaccine AstraZeneca (AZD1222)/Covishield

By: AstraZeneca and University of Oxford, the Serum Institute of India 

Type: Adenovirus vaccine    

Dosage: Two doses, between 4-12 weeks apart

For: UK, India, Argentina, Dominican Republic, El Salvador, Mexico, Morocco

Efficacy: Shown mixed results; was 70% effective when a half-dose was given before a full-dose booster, while two full doses showed an efficacy of 62%

Effect on mutant variants? “AZD1222 contains the genetic material of the SARS-CoV-2 virus spike protein, and the changes to the genetic code seen in this new viral strain do not appear to change the structure of the spike protein.”

Vaccine: Sputnik V

By: Gamaleya Research Institute, Russia (collaboration with Dr. Reddy’s Laboratories)

Type: Adenoviral vaccine     

Dosage: Two doses, 28 days apart

For: No distribution list

Efficacy: 91.4% (on day 28 of first dose) and over 95% (on day 42 of second dose) 

Effect on mutant variants? “Sputnik V will be as highly effective against the new strain of the coronavirus found in Europe as against the existing strains. Sputnik V has been showing its efficacy over a period of time despite the previous mutations of S-protein,” according to Sputnik V’s Twitter handle. 

VACCINE: Covaxin 

By: Bharat Biotech with Indian Council of Medical Research, India’s National Institute of Virology

Type: Whole virion inactivated

Dosage: Two doses, 14-28 days apart

For: India

Efficacy: No percentage reported

Effect on mutant variants? “Potential of Covaxin to mount resistance against mutants of SARS-Cov-2, the virus causing Covid-19, informed the decision making process for vaccine approval,” according to ICMR notification.

VACCINE: CoronaVac 

By: Sinovac Biotech Ltd, China

Type: Inactivated vaccine

Dosage: Two doses, 14-28 days apart

For: China, Brazil, Chile, Indonesia, Philippines

Efficacy: 78%

Effect on mutant variants? “The vaccine is safe, and we can use it with ease,” according to company statement.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp